Merck appoints Bridgette Heller
March 5, 2010Sales and Marketing Merck, appointment, consumer healthcare, sales and marketing
Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care. She moves to Merck …
Just teams up with sexual health charity
March 5, 2010Medical Communications FPA, charity, contraception, just health pr
Just Health PR is providing PR support for the launch of a new UK consumer book on contraception from sexual …
Kantar Health promotes Ceri Thomas
March 4, 2010Sales and Marketing Kantar Health, appointment, sales and marketing
Ceri Thomas has been promoted to head of global marketing at healthcare consultancy and marketing insights company Kantar Health. In …
Pfizer suffers Alzheimer’s setback
March 4, 2010Research and Development Alzheimer's, Medivation, Pfizer
Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …
HCA: Five years of change in healthcare communications
March 4, 2010Medical Communications HCA, industry reputation
In 2005 the Healthcare Communications Association (HCA) conducted its first ever benchmarking survey, exploring trends in the provision of communications …
Lamberto Andreotti new head of Bristol-Myers Squibb
March 4, 2010Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …
Axon expands in the US
March 4, 2010Medical Communications Axon, medical communications
Surrey, UK-based Axon Communications has appointed Mario Nacinovich as managing director of its new US operations. Nacinovich will be based …
Stem cell therapy helps diabetes limb problems
March 3, 2010Research and Development ReNeuron, diabetes, stem cell
Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …
Generic Keppra hits UCB sales
March 3, 2010Sales and Marketing 2009 financials, Keppra, UCB
UCB’s sales fell 13% in 2009 as the pharma company faced the first full year of generic competition in the …
Funds keep Archimedes Pharma buoyant
March 3, 2010Research and Development Archimedes, funding
Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …
Awareness push for dementia
March 3, 2010dementia, disease awareness campaigns
The government’s offensive on dementia has continued with a new awareness campaign called Living Well, which aims to break down …
UK hit hard as AstraZeneca reveals R&D cuts
March 3, 2010Research and Development AstraZeneca, job cuts
Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …
Adrian Kemsley joins Ogilvy Healthworld
March 3, 2010Medical Communications Ogilvy, appointment, medical communications, ogilvy healthworld advertising
Ogilvy Healthworld Advertising has appointed Adrian Kemsley as creative director and overall lead for the agency and unveiled a new …
Dr Olaf Stange to head up Bayer Technology in Singapore
March 3, 2010Manufacturing and Production Bayer Technology Services, appointment, manufacturing and production
Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) …
Stability data issue holds up Adventrx cancer drug
March 3, 2010Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine
US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …
Digital Pharma: AZ outlines its online principles
March 2, 2010Medical Communications FDA, digital pharma, social media
AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions …
Astellas moves in on OSI Pharmaceuticals
March 2, 2010Sales and Marketing Astellas, Astellas Pharma Europe, OSI
Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …
Warner Chilcott sees major jump in revenue
March 2, 2010P&G, Warner Chilcott
Warner Chilcott saw a big increase in 2009 revenue thanks to its acquisition of Proctor and Gamble’s branded pharmaceuticals business. …
Merck shows off expanded pipeline
March 2, 2010Sales and Marketing Merck, Schering-Plough
Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …
Shire launches Vpriv to capitalise on Genzyme woes
March 2, 2010Sales and Marketing Cerezyme, Gaucher's, Shire
Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
